Carmen Bozic
EVP and CMO · 13 filings · Latest: Jun 15, 2026
VERTEX PHARMACEUTICALS INC / MA
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
VRTX | Bozic Carmen | — | Jun 18, 2026 | Proposed Sale | $462.17 | 1,020 | $471.4K | — | |
VRTX | Carmen Bozic | EVP and CMO | Jun 15, 2026 | Sale | $450.00 | 4,062 | $1.8M | 16,953 | |
VRTX | Bozic Carmen | — | Jun 15, 2026 | Proposed Sale | $450.00 | 4,062 | $1.8M | — | |
VRTX | Carmen Bozic | EVP and CMO | Jun 5, 2026 | Sale | $450.00 | 1,745 | $785.3K | 21,015 | |
VRTX | Bozic Carmen | — | Jun 5, 2026 | Proposed Sale | $450.00 | 1,745 | $785.3K | — | |
VRTX | Carmen Bozic | EVP and CMO | May 29, 2026 | Sale | $450.00 | 1,974 | $888.3K | 22,760 | |
VRTX | Bozic Carmen | — | May 29, 2026 | Proposed Sale | $450.00 | 1,974 | $888.3K | — | |
VRTX | Carmen Bozic | EVP and CMO | May 15, 2026 | Sale | $453.45 | 1,354 | $614.0K | 24,734 | |
VRTX | Bozic Carmen | — | May 15, 2026 | Proposed Sale | $453.45 | 1,354 | $614.0K | — | |
VRTX | Carmen Bozic | EVP and CMO | May 12, 2026 | Sale | $450.00 | 6,988 | $3.1M | 26,088 | |
VRTX | Bozic Carmen | — | May 12, 2026 | Proposed Sale | $450.00 | 6,988 | $3.1M | — | |
VRTX | Carmen Bozic | EVP and CMO | Mar 27, 2026 | Sale | $450.95 | 2,329 | $1.1M | 33,076 | |
VRTX | Bozic Carmen | — | Mar 27, 2026 | Proposed Sale | $450.95 | 2,329 | $1.1M | — | |
VRTX | Carmen Bozic | EVP and CMO | Mar 13, 2026 | Sale | $481.79 | 2,329 | $1.1M | 35,405 | |
VRTX | Bozic Carmen | — | Mar 13, 2026 | Proposed Sale | $481.79 | 2,329 | $1.1M | — | |
VRTX | Carmen Bozic | EVP and CMO | Feb 27, 2026 | Sale | $480.31 | 2,329 | $1.1M | 37,734 | |
VRTX | Bozic Carmen | — | Feb 27, 2026 | Proposed Sale | $480.31 | 2,329 | $1.1M | — |